Rufu Xu

451 total citations
20 papers, 279 citations indexed

About

Rufu Xu is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Oncology. According to data from OpenAlex, Rufu Xu has authored 20 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Epidemiology and 4 papers in Oncology. Recurrent topics in Rufu Xu's work include RNA Interference and Gene Delivery (2 papers), Colorectal Cancer Surgical Treatments (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Rufu Xu is often cited by papers focused on RNA Interference and Gene Delivery (2 papers), Colorectal Cancer Surgical Treatments (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Rufu Xu collaborates with scholars based in China. Rufu Xu's co-authors include Chunji Huang, Xuelian Hu, Zhang Zuo, Jiyin Zhou, Guisheng Qian, Wenjing Lai, Guobing� Li, Qian Ren, Caizhong Zhu and Yafei Li and has published in prestigious journals such as PLoS ONE, Cochrane Database of Systematic Reviews and BioMed Research International.

In The Last Decade

Rufu Xu

20 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rufu Xu China	11	82	66	44	34	31	20	279
Thiago Martins Santos Brazil	10	57 0.7×	28 0.4×	17 0.4×	21 0.6×	23 0.7×	31	286
Alex Williamson United States	10	41 0.5×	37 0.6×	19 0.4×	45 1.3×	27 0.9×	36	287
Yiliang Su China	13	84 1.0×	265 4.0×	14 0.3×	33 1.0×	45 1.5×	21	412
Aartik Sarma United States	9	93 1.1×	84 1.3×	10 0.2×	17 0.5×	41 1.3×	22	267
Niamh Foley Ireland	10	58 0.7×	121 1.8×	12 0.3×	23 0.7×	73 2.4×	12	406
Sabri Kemahlı Türkiye	13	77 0.9×	22 0.3×	18 0.4×	52 1.5×	14 0.5×	34	349
James A. Town United States	10	58 0.7×	76 1.2×	10 0.2×	27 0.8×	130 4.2×	28	453
Kristian Madeira Brazil	9	84 1.0×	18 0.3×	15 0.3×	40 1.2×	22 0.7×	62	252
Sérgio Marrone Ribeiro Brazil	11	42 0.5×	164 2.5×	12 0.3×	8 0.2×	35 1.1×	42	328
Cristiano Claudino Oliveira Brazil	8	26 0.3×	23 0.3×	12 0.3×	74 2.2×	17 0.5×	50	258

Countries citing papers authored by Rufu Xu

Since Specialization

Citations

This map shows the geographic impact of Rufu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rufu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rufu Xu more than expected).

Fields of papers citing papers by Rufu Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rufu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rufu Xu. The network helps show where Rufu Xu may publish in the future.

Co-authorship network of co-authors of Rufu Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Rufu Xu. A scholar is included among the top collaborators of Rufu Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rufu Xu. Rufu Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Wuyi, Huyue Zhou, Wenjing Lai, et al.. (2024). The immunosuppressive landscape in tumor microenvironment. Immunologic Research. 72(4). 566–582. 12 indexed citations

Wang, Fengling, Wenjing Lai, Dandan Xie, et al.. (2024). Nanoparticle-mediated celastrol ER targeting delivery amplify immunogenic cell death in melanoma. Journal of Advanced Research. 71. 585–601. 11 indexed citations

Li, Yulian, Min Hu, Zhe Zhang, et al.. (2024). Cost‐effectiveness analysis of continuing bevacizumab plus chemotherapy versus chemotherapy alone after first progression of metastatic colorectal cancer. Cancer Medicine. 13(1). e6904–e6904. 2 indexed citations

Guo, Junfeng, Fangfang Sheng, Rufu Xu, et al.. (2023). Association between antihypertensive drugs and oral cancer: a drug target Mendelian randomization study. Frontiers in Pharmacology. 14. 1294297–1294297. 3 indexed citations

Wu, Dongdong, et al.. (2023). Economic Evaluation of Neoadjuvant Versus Adjuvant Chemotherapy in Cancer Treatment: A Systematic Review and Meta-Analysis. Value in Health Regional Issues. 41. 15–24. 1 indexed citations

Zhou, Min, Wenjing Lai, Rufu Xu, et al.. (2023). A celastrol-based nanodrug with reduced hepatotoxicity for primary and metastatic cancer treatment. EBioMedicine. 94. 104724–104724. 18 indexed citations

Dai, Yue, Changpeng� Hu, Huyue Zhou, et al.. (2023). Rucaparib inhibits lung adenocarcinoma cell proliferation and migration via the SHCBP1/CDK1 pathway. FEBS Journal. 290(24). 5720–5743. 5 indexed citations

Xu, Rufu, et al.. (2022). Nomograms for Predicting the Risk of SIRS and Urosepsis after Uroscopic Minimally Invasive Lithotripsy. BioMed Research International. 2022(1). 6808239–6808239. 11 indexed citations

Hu, Changpeng�, Yue Dai, Huyue Zhou, et al.. (2022). Identification of GINS1 as a therapeutic target in the cancer patients infected with COVID-19: a bioinformatics and system biology approach. Hereditas. 159(1). 45–45. 1 indexed citations

10.

Wang, Fengling, Dandan Xie, Wenjing Lai, et al.. (2022). Autophagy responsive intra-intercellular delivery nanoparticles for effective deep solid tumor penetration. Journal of Nanobiotechnology. 20(1). 300–300. 9 indexed citations

11.

Xu, Rufu, et al.. (2022). A comparison of qSOFA, SIRS and NEWS in predicting the accuracy of mortality in patients with suspected sepsis: A meta-analysis. PLoS ONE. 17(4). e0266755–e0266755. 31 indexed citations

12.

Zhang, Lei, Liuqing Yang, Wen Li, et al.. (2020). Noninvasively Evaluating the Grading of Glioma by Multiparametric Magnetic Resonance Imaging. Academic Radiology. 28(5). e137–e146. 15 indexed citations

13.

Duan, Guangyou, et al.. (2018). Protocol for a randomised, double-blind, placebo-controlled trial to explore the effect of tramadol in the prevention of postpartum depression (ETPPD). BMJ Open. 8(10). e022538–e022538. 4 indexed citations

14.

Zhou, Jiyin, et al.. (2016). Effectiveness of problem-based learning in Chinese pharmacy education: a meta-analysis. BMC Medical Education. 16(1). 23–23. 50 indexed citations

15.

Ren, Ran, Yan Zhang, Jianyun Zhou, et al.. (2016). Diagnostic value of fibulin-3 for malignant pleural mesothelioma: A systematic review and meta-analysis. Oncotarget. 7(51). 84851–84859. 23 indexed citations

16.

He, Siyi, Kailong Lin, Ruiyan Ma, Rufu Xu, & Yingbin Xiao. (2015). Effect of the Urinary Tryptin Inhibitor Ulinastatin on Cardiopulmonary Bypass–Related Inflammatory Response and Clinical Outcomes: A Meta-Analysis of Randomized Controlled Trials. Clinical Therapeutics. 37(3). 643–653. 16 indexed citations

17.

Liu, Fang, Jing Ouyang, Atul Sharma, et al.. (2015). Leukotriene inhibitors for bronchiolitis in infants and young children. Cochrane Database of Systematic Reviews. 2015(3). CD010636–CD010636. 31 indexed citations

18.

Xiang, Ying, Ying Li, Jie Liu, et al.. (2011). An epidemiological study of resistant tuberculosis in Chongqing, China. Journal of Medical Colleges of PLA. 26(3). 158–173. 2 indexed citations

19.

Zhang, Lu, et al.. (2010). Change in Coping Strategies Following Intensive Intervention for Special‐service Military Personnel as Civil Emergency Responders. Journal of Occupational Health. 53(1). 36–44. 8 indexed citations

20.

Ren, Qian, Hongyan Xiong, Yafei Li, Rufu Xu, & Caizhong Zhu. (2009). Evaluation of an outside-the-Cold-Chain Vaccine Delivery Strategy in Remote Regions of Western China. Public Health Reports. 124(5). 745–750. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact